The protein expression market is projected to grow from $2.7 billion in 2024 to $6.3 billion by 2035, representing a CAGR of 8.0%, during the forecast period, till 2035.
Although protein therapeutics offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are generally associated with high costs of development and complex manufacturing protocols. This has prompted various industry stakeholders to adopt novel protein expression systems with advanced features for the production of recombinant proteins. The protein expression market is presently characterized by the presence of both niche, specialty protein expression companies, focused solely on expressing proteins, and one-stop-shops, which have, over time, acquired an extensive range of capabilities to cater to essentially all the requirements of sponsors including custom protein expression services.
The increasing awareness in the domain of protein expression is evident from number of key strategic initiatives undertaken by leading companies in the recent past
With a strong focus on continuous innovation and sustainability, companies, including Agilent, Ajinomoto Bio-pharma Services and other leading players claim to provide protein expression systems and related offerings through their various collaborations and initiatives in the pharmaceutical industry. In order to augment the protein expression portfolio, we expect the companies to continue seeking collaboration opportunities with other leading players that offer innovative solutions and expand their respective offerings.
Foreseeing lucrative returns, many new entrants are stepping into the market; however, a number of factors presently affect the overall protein expression industry, which need to be considered by these new players
The high costs involved in protein expression process pose a significant barrier for firms looking to exit the industry. Protein expression involves complex biological processes and requires expertise in molecular biology, cell culture and protein purification, which can limit its adoption and scalability, particularly for companies having insufficient technical know-how and resources.
In addition, the protein expression market is a flourishing domain wherein the product providers are currently focusing on developing technologically advanced novel protein expression systems in order to cater the growing demands of their clientele.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the protein expression market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
+1 (415) 800 3415
